Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 9/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 7/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.77 |
| ▸ | PGR | P06401 | 4/20 | 0.77 |
| ▸ | AR | P10275 | 3/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.77 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | APEX1 | P27695 | 1/20 | 0.77 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beclomethasone SCHEMBL5037570 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL1462741 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL18762039 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL13046625 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL8809468 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL3183 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL7614763 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL5486743 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL5037573 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA | |
| Beclomethasone SCHEMBL5486747 | 1.00 | HIF1A (1.00) | HIF1ACYP3A4NR3C1NFKB1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-3711797-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2025-02-12 | — | — | EP | claimed |
| EP-4434588-A2 | AEROSOL DELIVERY DEVICE AND METHOD OF OPERATING THE AEROSOL DELIVERY DEVICE | PARI Pharma GmbH (DE) | 2024-09-25 | — | — | EP | claimed |
| WO-2024189434-A1 | USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2024-09-19 | — | — | WO | claimed |
| EP-4426355-A1 | GLYCOSYLATED PRODRUGS | Universiteit Leiden (NL) | 2024-09-11 | — | — | EP | claimed |
| WO-2024085820-A1 | A PACKAGING TECHNIQUE FOR DRY POWDER INHALER | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2024-04-25 | — | — | WO | claimed |
| WO-2024010538-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION USING DIFFERENT MIXERS | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2024-01-11 | — | — | WO | claimed |
| WO-2024010539-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION USING DIFFERENT MIXERS | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2024-01-11 | — | — | WO | claimed |
| US-20230381102-A1 | RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS | CRESCITA THERAPEUTICS INC. (CA) | 2023-11-30 | — | — | US | claimed |
| WO-2023128918-A1 | A PROCESS INCLUDING A FEEDING GAS SYSTEM FOR PREPARING DRY POWDER INHALATION COMPOSITIONS | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2023-07-06 | — | — | WO | claimed |
| WO-2022231533-A1 | PROCESS FOR THE PREPARATION OF STERILIZED SUSPENSIONS FOR THE INHALATION BY NEBULIZATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-11-03 | — | — | WO | claimed |
| WO-2022146254-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-07-07 | — | — | WO | claimed |
| WO-2022146255-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-07-07 | — | — | WO | claimed |
| WO-2022146257-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-07-07 | — | — | WO | claimed |
| WO-2022098321-A1 | PROCESS FOR THE PREPARATION OF STERILISED SUSPENSIONS FOR THE ADMINISTRATION BY INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-05-12 | — | — | WO | claimed |
| WO-2022045994-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-03-03 | — | — | WO | claimed |
| WO-2022045995-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-03-03 | — | — | WO | claimed |
| WO-2022045993-A1 | A PRODUCTION METHOD OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2022-03-03 | — | — | WO | claimed |
| EP-0170500-B1 | NOVEL 9 ALPHA-FLUORO- OR CHLORO-CORTICOSTEROID ESTERS AND A PROCESS FOR THEIR PREPARATION | HOVIONE INTER LTD. (CH) | 1990-10-10 | — | — | EP | claimed |
| EP-0072200-B1 | STEROIDAL ESTERS AND PROCESS FOR THE PREPARATION OF STEROIDAL ESTERS | PLURICHEMIE ANSTALT (LI) | 1985-11-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381102-A1 | RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS | PLOD3, DSG1, POLR1C | HIF1A 1712/4885CYP3A4 4551/4885NR3C1 3473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.